|Articles|March 1, 2018
Enhanced Expression of Growth Factor-β Type II Receptor PDF
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
3
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
4
Containment to Protection: Packaging Trends Impacting Biopharma
5